SAHPRA: Ensures Field Safety Corrective Actions for Medical Devices

• A Field Safety Corrective Action (FSCA) is a manufacturer-initiated measure to minimize risks from medical devices or IVDs already on the market.
• SAHPRA provides regulatory oversight for FSCAs, ensuring compliance with the Medicines and Related Substances Act.
• FSCAs are triggered by adverse incidents and aim to prevent harm to patients and users.
• SAHPRA communicates Safety Warning Notices through its website, social media, and mainstream media.
• These notices inform stakeholders about risks and provide guidance on handling affected products.

The primary objective of these actions is to reduce the risk of harm, including death or deterioration of health, for patients and users of these products.

A Field Safety Corrective Action (FSCA), also known as a Safety Warning Notice, represents a critical measure initiated by manufacturers to mitigate potential hazards associated with medical devices or In-Vitro Diagnostics (IVDs) that are already in circulation within the market. The primary objective of these actions is to reduce the risk of harm, including death or deterioration of health, for patients and users of these products. This proactive approach ensures that any identified safety concerns are addressed promptly after a product has been distributed.

Unlike a direct recall, which is a regulatory directive from the South African Health Products Regulatory Authority (SAHPRA) to remove a medical device or IVD from the market or from users entirely, an FSCA focuses on minimizing the safety risk while the product may still be in use. An FSCA or Safety Warning Notice is typically triggered following the occurrence of one or more medical device adverse incidents in South Africa. These incidents indicate that a device or IVD already on the market possesses the potential to cause harm or present a safety risk if its use continues unchecked.

SAHPRA plays a pivotal role in the oversight and communication of these safety measures, publishing Field Safety Notices or Safety Warning Notices to ensure timely dissemination of crucial safety information regarding medical devices and IVDs to all relevant stakeholders, including patients, healthcare professionals, and end-users. When a license holder or certificate of registration holder initiates an FSCA or SAHPRA safety warning notice, the regulatory body provides essential oversight. This ensures that all actions taken are in full compliance with the provisions of the Medicines and Related Substances Act, specifically concerning medical devices and IVDs.

The scope and nature of Safety Warning Notices or FSCAs are determined by SAHPRA based on a thorough assessment of the specific medical device or IVD involved and the potential extent of the safety risk to public health. Depending on this risk evaluation, SAHPRA may mandate the immediate discontinuation of a medical device or IVD's use. Alternatively, it might permit continued use, provided that appropriate risk information and corrective measures are effectively communicated to all affected parties, including patients and healthcare professionals. This regulatory flexibility allows for tailored responses to varying levels of risk.

Effective communication is a cornerstone of SAHPRA's strategy for managing medical device safety. Following the outcome of a medical device or IVD risk assessment, a Safety Warning Notice or Field Safety Notice may be officially published and disseminated through various channels. These include SAHPRA’s official website and social media platforms, and, where deemed necessary, through mainstream media outlets to reach a broader audience. This multi-channel approach ensures that critical information about South Africa IVD safety warnings and medical device safety reaches those who need it most.

The primary goal of this widespread communication is to inform the public, patients, and healthcare professionals about the specific safety risks associated with the affected medical device or IVD. Furthermore, these notices provide clear guidance on how to properly handle any affected batches of the product. This comprehensive approach to SAHPRA Field Safety Corrective Actions underscores the authority's commitment to protecting public health and ensuring the safe use of medical technologies in South Africa.

Compliance officers and legal counsel for medical device manufacturers and distributors in South Africa must understand SAHPRA's process for Field Safety Corrective Actions and safety warning notices to ensure timely and compliant responses to minimize risks and adhere to the Medicines and Related Substances Act.

Source: Original reporting via SAHPRA's official guidelines